ZA200610546B - FGFR binding peptides - Google Patents
FGFR binding peptidesInfo
- Publication number
- ZA200610546B ZA200610546B ZA200610546A ZA200610546A ZA200610546B ZA 200610546 B ZA200610546 B ZA 200610546B ZA 200610546 A ZA200610546 A ZA 200610546A ZA 200610546 A ZA200610546 A ZA 200610546A ZA 200610546 B ZA200610546 B ZA 200610546B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- ncam
- fgfr
- peptide sequences
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 108091008794 FGF receptors Proteins 0.000 title abstract 4
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 abstract 4
- 102100023616 Neural cell adhesion molecule L1-like protein Human genes 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 abstract 3
- 102000002090 Fibronectin type III Human genes 0.000 abstract 1
- 108050009401 Fibronectin type III Proteins 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003061 neural cell Anatomy 0.000 abstract 1
- 230000014511 neuron projection development Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Psychology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400963 | 2004-06-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200610546B true ZA200610546B (en) | 2008-06-25 |
Family
ID=35510321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200610546A ZA200610546B (en) | 2004-06-18 | 2006-12-15 | FGFR binding peptides |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090074774A1 (pt-PT) |
| EP (1) | EP1765861B1 (pt-PT) |
| JP (1) | JP2008504236A (pt-PT) |
| CN (1) | CN101027320A (pt-PT) |
| AT (1) | ATE545655T1 (pt-PT) |
| AU (1) | AU2005254613A1 (pt-PT) |
| BR (1) | BRPI0512254A (pt-PT) |
| CA (1) | CA2570267A1 (pt-PT) |
| MX (1) | MXPA06014804A (pt-PT) |
| WO (1) | WO2005123759A2 (pt-PT) |
| ZA (1) | ZA200610546B (pt-PT) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1886422A (zh) * | 2003-09-30 | 2006-12-27 | 恩卡姆医药公司 | 调节细胞存活、分化和/或突触可塑性的方法 |
| EP2412727B1 (en) | 2006-02-14 | 2016-06-29 | University Of Tasmania Through The Menzies Research Institute | Metallothionein-derived peptide fragments |
| WO2007110079A2 (en) * | 2006-03-29 | 2007-10-04 | Enkam Pharmaceuticals A/S | Targeted delivery of fgfr ligands into the brain |
| CN101619093B (zh) * | 2009-05-26 | 2011-12-07 | 中国人民解放军第三军医大学野战外科研究所 | 具有促进成纤维细胞生长因子受体3活性的多肽及其筛选方法和应用 |
| EP2483407A2 (en) | 2009-09-30 | 2012-08-08 | President and Fellows of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| ES2673872T3 (es) | 2012-06-05 | 2018-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Mimético del péptido NCAM para su uso en el tratamiento de trastorno de depresión mayor |
| CN109867724B (zh) * | 2019-04-19 | 2020-09-15 | 温州医科大学 | 一种fgfr抗体及其在脊髓损伤治疗中的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4036945A (en) * | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
| US4331647A (en) * | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US4599311A (en) * | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5693488A (en) * | 1994-05-12 | 1997-12-02 | The Rockefeller University | Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and methods of use thereof |
| US20020104122A1 (en) * | 1994-06-17 | 2002-08-01 | Kirin Beer Kabushiki Kaisha | Methods for producing a plant with enhanced resistance to pathogenic fungi |
| EP2275551B1 (en) * | 1999-10-29 | 2015-04-08 | Novartis Vaccines and Diagnostics S.r.l. | Neisserial antigenic peptides |
| GB0014870D0 (en) * | 2000-06-16 | 2000-08-09 | King S College London | Peptides |
| CA2457164A1 (en) * | 2001-08-17 | 2003-02-27 | Enkam Pharmaceuticals A/S | Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| WO2005049641A2 (en) * | 2003-11-21 | 2005-06-02 | Ace Biosciences A/S | Surface-located campylobacter jejuni polypeptides |
-
2005
- 2005-06-17 CN CNA2005800284125A patent/CN101027320A/zh active Pending
- 2005-06-17 AU AU2005254613A patent/AU2005254613A1/en not_active Abandoned
- 2005-06-17 AT AT05748535T patent/ATE545655T1/de active
- 2005-06-17 WO PCT/DK2005/000400 patent/WO2005123759A2/en active Application Filing
- 2005-06-17 EP EP05748535A patent/EP1765861B1/en active Active
- 2005-06-17 CA CA002570267A patent/CA2570267A1/en not_active Abandoned
- 2005-06-17 US US11/629,896 patent/US20090074774A1/en not_active Abandoned
- 2005-06-17 MX MXPA06014804A patent/MXPA06014804A/es not_active Application Discontinuation
- 2005-06-17 BR BRPI0512254-6A patent/BRPI0512254A/pt not_active Application Discontinuation
- 2005-06-17 JP JP2007515781A patent/JP2008504236A/ja active Pending
-
2006
- 2006-12-15 ZA ZA200610546A patent/ZA200610546B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101027320A (zh) | 2007-08-29 |
| ATE545655T1 (de) | 2012-03-15 |
| JP2008504236A (ja) | 2008-02-14 |
| EP1765861B1 (en) | 2012-02-15 |
| CA2570267A1 (en) | 2005-12-29 |
| BRPI0512254A (pt) | 2008-02-19 |
| EP1765861A2 (en) | 2007-03-28 |
| WO2005123759A2 (en) | 2005-12-29 |
| WO2005123759A3 (en) | 2006-05-04 |
| MXPA06014804A (es) | 2007-03-23 |
| AU2005254613A1 (en) | 2005-12-29 |
| WO2005123759A8 (en) | 2006-03-09 |
| US20090074774A1 (en) | 2009-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200610546B (en) | FGFR binding peptides | |
| WO2007051477A8 (en) | Neurotrophin-derived peptide sequences | |
| EP2385061A3 (en) | Neuritogenic peptides | |
| WO2006125227A3 (en) | Fibroblast activation protein inhibitor compounds and methods | |
| WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
| WO2007093177A3 (en) | Metallothionein-derived peptide fragments | |
| WO2007117657A3 (en) | Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency | |
| DE602004027508D1 (de) | Lpa-haltige verbindungen | |
| WO2007146085A3 (en) | Creatine phosphate prodrugs, compositions and uses thereof | |
| WO2006110588A3 (en) | Methods for treating mild cognitive impairment | |
| WO2007074456A3 (en) | Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids | |
| WO2000018801A3 (en) | Ncam binding compounds | |
| WO2007013358A3 (en) | Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent | |
| WO2002074956A3 (en) | Dopaminergic neuronal survival-promoting factors and uses thereof | |
| ATE552273T1 (de) | Verbindungen, die die differenzierung, proliferation, regeneration, plastizität und das überleben von zellen beeinflussen können | |
| WO2005118920A3 (en) | Methods for generating neuronal cells from human embryonic stem cells and uses thereof | |
| WO2007045243A3 (en) | Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 | |
| WO2009068042A3 (en) | Novel peptides derived from ncam (fgls) | |
| WO2007071248A8 (en) | Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins | |
| WO2005025514A3 (en) | Compounds that modulate neuronal growth and their uses | |
| WO2005121168A3 (en) | Heparin binding peptide | |
| IL176898A0 (en) | Growth factor-binding compounds and methods of use | |
| WO2003097687A3 (en) | Neuroprotective polypeptides and methods of use | |
| Janke et al. | The arginine mimicking β-amino acid β3hPhe (3-H2N-CH2) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors | |
| DK1438329T3 (da) | Biologisk aktive peptider og deres anvendelse til reparation af beskadigede nerver |